Aya Mohamed | MSc, MD 馃帡路 @Dr_Oncologista 路 X路路 3 days agoScore70
Body
OptiTROP-Lung06 馃珌
Sac-TMT + pembrolizumab: A substantial PFS benefit in 1L PD-L1-negative advanced NSCLC, with OS data still immature.
@OncoAlert #ESMO26 #LungCancer #Lcsm #ESMOAmbassadors #ESMOcommunity @myESMO
66 views 路 5 likes 路 3 reposts 路 0 replies
Source: Aya Mohamed | MSc, MD 馃帡 路 x.com